Eyego (Drug Delivery) Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
Eyego (Drug Delivery) General Information
Description
Manufacturer of an ophthalmic drug delivery system designed to replace conventional eye drops with precision microdosing. The company's technology utilizes a high-precision micropump to deliver a controlled mist that matches the eye's natural capacity, enabling patients to administer medication more accurately and comfortably while reducing systemic absorption and overmedication.
Contact Information
Website
www.eye-go.comCorporate Office
- Agern Allé 5A
- 2970 Hoersholm
- Denmark
Corporate Office
- Agern Allé 5A
- 2970 Hoersholm
- Denmark
Eyego (Drug Delivery) Timeline
Eyego (Drug Delivery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Secondary Transaction - Private | 01-Jan-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 19-May-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 02-Jun-2023 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 07-Jan-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 08-Apr-2022 | Completed | Generating Revenue | |||
| 6. Debt - General | Completed | Generating Revenue | ||||
| 5. Later Stage VC | 10-Dec-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Startup | ||||
| 3. Accelerator/Incubator | 01-Jul-2020 | $75.5K | $3.14M | Completed | Startup | |
| 2. Early Stage VC | 21-Dec-2017 | $3.06M | $3.06M | Completed | Startup |
Eyego (Drug Delivery) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 96,240 | $5.77 | $5.77 | 1x | $5.77 | 2.9% | ||
| Ordinary | 15,334 | $4.37 | $4.37 | 1x | $4.37 | 0.46% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Eyego (Drug Delivery) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Eyego (Drug Delivery) Patents
Eyego (Drug Delivery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026115119-A1 | A device comprising a sensing unit for validating the administration of a mist of a dose of ophthalmic liquid, and a dispersion unit suitable for the delivery of a mist of an ophthalmic liquid, and a sensing unit, therefore | Pending | 29-Nov-2024 | ||
| WO-2026115122-A1 | A device for the delivery of a mist of a dose of an ophthalmic liquid and a pump suitable for devices for the delivery of a mist of an ophthalmic liquid | Pending | 29-Nov-2024 | ||
| WO-2026115124-A1 | A device for the delivery of a mist of a dose of an ophthalmic liquid and a pump suitable for devices for the delivery of a mist of an ophthalmic liquid | Pending | 29-Nov-2024 | ||
| EP-4251104-B1 | A device for the delivery of a mist of a dose of an ophthalmic liquid | Active | 30-Nov-2020 | ||
| CA-3203449-A1 | A device for the delivery of a mist of a dose of an ophthalmic liquid, and a pump suitable for devices for the delivery of a mist of an ophthalmic liquid | Pending | 30-Nov-2020 | A61F9/0026 |
Eyego (Drug Delivery) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Eyego (Drug Delivery) Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Topcon Healthcare | VC-Backed Company | Minority | ||
| Lighthouse Life Sciences | Corporation | Minority | ||
| North Ventures | Venture Capital | Minority | ||
| Maj Invest | PE/Buyout | Minority | ||
| Innovationsfonden | Accelerator/Incubator | Minority |
Eyego (Drug Delivery) FAQs
-
When was Eyego (Drug Delivery) founded?
Eyego (Drug Delivery) was founded in 2015.
-
Where is Eyego (Drug Delivery) headquartered?
Eyego (Drug Delivery) is headquartered in Hoersholm, Denmark.
-
What is the size of Eyego (Drug Delivery)?
Eyego (Drug Delivery) has 7 total employees.
-
What industry is Eyego (Drug Delivery) in?
Eyego (Drug Delivery)’s primary industry is Drug Delivery.
-
Is Eyego (Drug Delivery) a private or public company?
Eyego (Drug Delivery) is a Private company.
-
What is Eyego (Drug Delivery)’s current revenue?
The current revenue for Eyego (Drug Delivery) is .
-
How much funding has Eyego (Drug Delivery) raised over time?
Eyego (Drug Delivery) has raised $7.07M.
-
Who are Eyego (Drug Delivery)’s investors?
Topcon Healthcare, Lighthouse Life Sciences, North Ventures, Maj Invest, and Innovationsfonden are 5 of 6 investors who have invested in Eyego (Drug Delivery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
